Immune checkpoint inhibitors show setting specific benefit in ovarian cancer meta analysis of 17 randomised trials
Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
Immune checkpoint inhibitors show setting specific benefit in ovarian cancer meta analysis of 17 randomised trials
P-32 microparticle brachytherapy plus FOLFIRINOX shows promising local control in unresectable pancreatic cancer
Therapeutic Mammoplasty: An advanced oncoplastic breast surgery technique
Adagrasib plus cetuximab shows activity but does not improve survival in KRAS G12C-mutated metastatic colorectal cancer
Zolbetuximab plus chemo in CLDN18.2-positive metastatic pancreatic cancer does not improve OS
ctDNA MRD status predicts survival and adjuvant chemo benefit in resected colorectal liver metastas
Talquetamab plus daratumumab with or without pomalidomide improves PFS in r/r multiple myeloma
Defining breast cancer quality care around the globe
Global oncology innovations: B.J. Kennedy award for geriatric oncology
Global disparities in cancer care for conflict-affected populations: Africa's neglected crisis
Novel therapies in mCRPC: Tarlatamab targeting DLL3 shows early activity in neuroendocrine mCRPC
The evolving treatment landscape in immune thrombocytopenia